BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26660426)

  • 1. Essential control of early B-cell development by Mef2 transcription factors.
    Herglotz J; Unrau L; Hauschildt F; Fischer M; Kriebitzsch N; Alawi M; Indenbirken D; Spohn M; Müller U; Ziegler M; Schuh W; Jäck HM; Stocking C
    Blood; 2016 Feb; 127(5):572-81. PubMed ID: 26660426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEF2C and EBF1 Co-regulate B Cell-Specific Transcription.
    Kong NR; Davis M; Chai L; Winoto A; Tjian R
    PLoS Genet; 2016 Feb; 12(2):e1005845. PubMed ID: 26900922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmentally regulated expression of MEF2C limits the response to BCR engagement in transitional B cells.
    Andrews SF; Dai X; Ryu BY; Gulick T; Ramachandran B; Rawlings DJ
    Eur J Immunol; 2012 May; 42(5):1327-36. PubMed ID: 22311635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERK5 Cooperates With MEF2C to Regulate Nr4a1 Transcription in MA-10 and MLTC-1 Leydig Cells.
    de Mattos K; Dumas FO; Campolina-Silva GH; Belleannée C; Viger RS; Tremblay JJ
    Endocrinology; 2023 Aug; 164(9):. PubMed ID: 37539861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MEF2C regulates c-Jun but not TNF-alpha gene expression in stimulated mast cells.
    Wei X; Sun W; Fan R; Hahn J; Joetham A; Li G; Webb S; Garrington T; Dakhama A; Lucas J; Johnson GL; Gelfand EW
    Eur J Immunol; 2003 Oct; 33(10):2903-9. PubMed ID: 14515274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow-induced Mef2c deficiency delays B-cell development and alters the expression of key B-cell regulatory proteins.
    Debnath I; Roundy KM; Pioli PD; Weis JJ; Weis JH
    Int Immunol; 2013 Feb; 25(2):99-115. PubMed ID: 23087187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel role for extracellular signal-regulated kinase 5 and myocyte enhancer factor 2 in medulloblastoma cell death.
    Sturla LM; Cowan CW; Guenther L; Castellino RC; Kim JY; Pomeroy SL
    Cancer Res; 2005 Jul; 65(13):5683-9. PubMed ID: 15994942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients.
    Arosio A; Sala G; Rodriguez-Menendez V; Grana D; Gerardi F; Lunetta C; Ferrarese C; Tremolizzo L
    Mol Cell Neurosci; 2016 Jul; 74():10-7. PubMed ID: 26921792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDAC7 is a repressor of myeloid genes whose downregulation is required for transdifferentiation of pre-B cells into macrophages.
    Barneda-Zahonero B; Román-González L; Collazo O; Rafati H; Islam AB; Bussmann LH; di Tullio A; De Andres L; Graf T; López-Bigas N; Mahmoudi T; Parra M
    PLoS Genet; 2013 May; 9(5):e1003503. PubMed ID: 23696748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel adaptor protein Swiprosin-1 enhances BCR signals and contributes to BCR-induced apoptosis.
    Avramidou A; Kroczek C; Lang C; Schuh W; Jäck HM; Mielenz D
    Cell Death Differ; 2007 Nov; 14(11):1936-47. PubMed ID: 17673920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Freeze-responsive regulation of MEF2 proteins and downstream gene networks in muscles of the wood frog, Rana sylvatica.
    Aguilar OA; Hadj-Moussa H; Storey KB
    J Therm Biol; 2017 Jul; 67():1-8. PubMed ID: 28558931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C.
    Kato Y; Kravchenko VV; Tapping RI; Han J; Ulevitch RJ; Lee JD
    EMBO J; 1997 Dec; 16(23):7054-66. PubMed ID: 9384584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation and alternative pre-mRNA splicing converge to regulate myocyte enhancer factor 2C activity.
    Zhu B; Gulick T
    Mol Cell Biol; 2004 Sep; 24(18):8264-75. PubMed ID: 15340086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERK5 regulates basic fibroblast growth factor-induced type 1 plasminogen activator inhibitor expression and cell proliferation in lung fibroblasts.
    Han JH; Hwang AR; Nam DH; Kim S; Choi HC; Lim JH; Woo CH
    Life Sci; 2015 Aug; 135():1-8. PubMed ID: 26032256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of mitogen-activated protein kinases ERK1/2 and ERK5 by neurotrophins, neuronal activity, and cAMP in neurons.
    Cavanaugh JE; Ham J; Hetman M; Poser S; Yan C; Xia Z
    J Neurosci; 2001 Jan; 21(2):434-43. PubMed ID: 11160424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-talk between glycogen synthase kinase 3β (GSK3β) and p38MAPK regulates myocyte enhancer factor 2 (MEF2) activity in skeletal and cardiac muscle.
    Dionyssiou MG; Nowacki NB; Hashemi S; Zhao J; Kerr A; Tsushima RG; McDermott JC
    J Mol Cell Cardiol; 2013 Jan; 54():35-44. PubMed ID: 23137781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Load-induced transcriptional activation of c-jun in rat myocardium: regulation by myocyte enhancer factor 2.
    Nadruz W; Kobarg CB; Constancio SS; Corat PD; Franchini KG
    Circ Res; 2003 Feb; 92(2):243-51. PubMed ID: 12574153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mef2c is activated directly by myogenic basic helix-loop-helix proteins during skeletal muscle development in vivo.
    Dodou E; Xu SM; Black BL
    Mech Dev; 2003 Sep; 120(9):1021-32. PubMed ID: 14550531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Processing of CD74 by the Intramembrane Protease SPPL2a Is Critical for B Cell Receptor Signaling in Transitional B Cells.
    Hüttl S; Kläsener K; Schweizer M; Schneppenheim J; Oberg HH; Kabelitz D; Reth M; Saftig P; Schröder B
    J Immunol; 2015 Aug; 195(4):1548-63. PubMed ID: 26157172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5/BMK1.
    Yang CC; Ornatsky OI; McDermott JC; Cruz TF; Prody CA
    Nucleic Acids Res; 1998 Oct; 26(20):4771-7. PubMed ID: 9753748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.